Answers are grounded in this paper and cite their sources.
Evaluates myocardial tissue abnormalities in hepatitis C individuals, suggesting early treatment is beneficial.
We evaluated cardiac extracellular volume (ECV) fraction, a sign of inflammation and fibrosis, in 10 individuals with chronic Hepatitis C virus (HCV) infection prior to treatment using cardiac magnetic resonance (CMR) at 3 T. Compared to age-matched, healthy volunteers, HCV-infected individuals had significantly increased ECV fraction (0.30 ± 0.03 vs. 0.26 ± 0.03, p = 0.0036) regardless of myocardial damage markers, hypertension as a comorbidity, smoking pack-years or fibrosis stage. Our results show that untreated hepatitis C is associated with the development of extrahepatic manifestations even before the onset of liver fibrosis, highlighting that early HCV treatment is prudent to reduce all-cause morbidity.
No takes yet. Share an insight, caveat, or question.
D’Amore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: